Vitamin D3 for Life

Live Enlightened

Physiology

Tissue-Specific Vitamin D Metabolism and Gene Responses: Full Study

Previous related pageTissue-Specific Vitamin D Metabolism and Gene Responses: Study SummaryNext related pageAge-Related Changes in Vitamin D Metabolism, Activation and Clearance: Full Evidence Review
Study at a glance

What question did the studies ask?

Why can vitamin D produce different responses in different tissues? Ten primary studies examined how cells gain access to a starting vitamin D compound, make or break down active hormone, and change selected gene or cell responses.

What did they find?

Skin and immune-cell experiments found responses that depended on cell state, timing and the surrounding proteins. Mouse studies separated some local tissue effects from blood measurements. Two studies agreed that removing an intestinal breakdown enzyme did not clearly raise blood vitamin D metabolites, but disagreed about changes in local gene activity.

What does this mean?

A blood result does not measure every tissue’s local supply or response. Making active hormone, breaking it down, changing a gene message and improving tissue function are separate things to test. Other reviewed studies show that cell type, timing and how DNA is packaged also matter.

What are the limits?

Most of this evidence comes from laboratory cells and specially altered mice. The studies do not measure every hormone’s route or how much each human tissue makes and removes over time. Conflicting and unchanged results remain important, and the evidence does not establish a supplement dose or a general health benefit.

Read the full article below ↓

Vitamin D metabolism is distributed across tissues, but finding a relevant enzyme does not reveal how much active hormone a tissue produces, removes or uses. This review compares ten primary studies of local activation, breakdown and selected responses, then connects those findings with the broader evidence on cell-specific gene regulation. Its central question is how metabolic conditions help shape a tissue response, while preserving the distinction between a plausible pathway and a measured physiological outcome. For a shorter overview of the same evidence, see Tissue-Specific Vitamin D Metabolism and Gene Responses: Study Summary.

ComparisonWhat it addsWhat remains uncertain
Skin and activated immune cellsPerturbation-dependent gene or cytokine responses in specified settings.Clinical healing, general immune benefit and every hormone’s intracellular route.
Macrophage states and T-cell surroundingsProducer state, timing and carrier conditions alter the measured response.How these culture conditions map onto intact human tissues.
Spatial nonrenal product and kidney-targeted deletionLocal detection and blood-to-physiology distinctions.Quantitative source, export and clearance fluxes.
Fuchs and Fleet intestinal deletionBlood-metabolite agreement with different local gene findings.Which design difference explains the disagreement.
Metabolite profiles and protein processingCompensation and functional enzyme location matter.A universal local set point or each enzyme’s human contribution.
Shared cell/time/chromatin evidenceMetabolism is integrated with the responding cell’s regulatory context.Whether a molecular response produces useful tissue function.
This table compares levels of evidence rather than ranking tissues by benefit. RNA, protein, metabolite concentration, flux and physiological outcomes are different measurements.

What does a local vitamin D measurement show?

Vitamin D3, or cholecalciferol, is processed into 25-hydroxyvitamin D, the circulating precursor commonly measured in blood. CYP27B1 can convert that precursor into calcitriol, the active hormone also called 1,25-dihydroxyvitamin D. CYP24A1 participates in the breakdown of vitamin D metabolites. These enzyme names identify important parts of the pathway, but their presence alone does not measure the rate of production or removal inside a particular tissue. The pathway overview is Vitamin D Enzyme Pathways (CYP27B1 / CYP24A1).

A concentration records how much substance is present in a sampled compartment. Flux describes how much is made, removed or transferred over time. A stable concentration can coexist with changing production and removal, so the two measurements must not be treated as interchangeable. Likewise, increased enzyme RNA does not guarantee a matching increase in correctly located, functional protein. These distinctions matter when a local result is compared with a blood test. This distinction also frames Vitamin D Metabolism at the Cellular Level.

The route of signalling needs its own evidence. Intracrine activity involves production and use within a target cell. Autocrine signalling can involve release and return to the producing cell; paracrine signalling acts on a neighbouring cell. Finding conversion in a population of cells and a response in that culture does not trace every hormone molecule or prove that none left its producer. The studies below test different parts of this sequence. For the terminology, see Vitamin D and Intracrine Activity; the neighbouring-cell evidence is assessed in Paracrine Vitamin D Signalling: Full Study.

The evidence is therefore compared by model, perturbation and measured endpoint. Enzyme expression, active-hormone detection, gene RNA, cytokine release, mineral balance and tissue structure have different meanings. A coherent explanation can connect these layers while keeping the unmeasured steps visible. It should not assume that all variation between tissues is caused by metabolism rather than receptor function, cell state or other regulatory conditions.

Skin responses depend on context and species

Schauber and colleagues in 2007 studied human wounds, keratinocyte cultures and mouse wounds. Selected human-cell experiments linked a wound-related stimulus and precursor availability with increased CAMP, CD14 and TLR2 responses. These genes relate to antimicrobial and recognition pathways. Interfering with vitamin D activation or receptor activity reduced the tested response, making the result more informative than enzyme detection alone.

The mouse findings qualify a direct human-to-mouse translation. Wounds in mice lacking Cyp27b1 lost the detected CD14 induction, but murine Camp still increased without a clear genotype difference. The human CAMP result therefore cannot simply be copied into a universal mammalian antimicrobial pathway. A related biological label does not guarantee identical gene regulation across species.

The human wound and topical groups were small, and the mechanistic work relied on culture conditions, an inhibitor and global-null mice. Those approaches do not provide direct intracellular calcitriol measurements or isolate every possible inhibitor effect. The measured response was not a clinical demonstration of better wound healing or infection prevention. This study contributes a context-specific epithelial mechanism and a useful species boundary, rather than a general claim that more vitamin D improves injured skin.

Activated T cells: access and timing change the answer

Kongsbak and colleagues in 2014 examined activated human T cells in culture. CYP27B1 and VDR increased around days two to three, and calcitriol measured in culture fluid peaked near day three. Precursor exposure increased CD38, a protein measured on the T cells. Blocking conversion inhibited that precursor-associated response while retaining the response to directly supplied calcitriol. The comparison supports a conversion-dependent step in this setting, rather than inferring it from enzyme expression alone.

Serum and vitamin D-binding protein reduced precursor sensitivity and, under the tested carrier conditions, suppressed conversion and selected responses more strongly than the response to active hormone. The time course also matters: an early measurement need not capture the later capacity of activated cells. Uptake of a carrier protein does not by itself show that its precursor becomes available for a particular response. The surrounding medium can change the result even when cells express relevant machinery.

The experiments used donor-derived cells, but not intact human tissues. Product measured in culture fluid and a response across the cell population do not establish exclusive intracellular retention. Nor do the results define a clinical target for free vitamin D or prove that lowering binding protein would benefit a person. Their contribution is the experimentally demonstrated dependence on activation time, precursor and carrier conditions.

Macrophage state changes neighbouring-cell responses

Villalba Lopez and colleagues in 2021 compared human macrophages under two laboratory activation programmes, labelled M1 and M2. M1-condition cells produced calcitriol faster and to a greater measured extent than M2-condition cells and isolated T cells. At the highest tested binding-protein condition, appreciable production persisted in M1 cells and M1/T-cell co-cultures, while M2 and isolated T-cell production were more strongly suppressed. Recipient T-cell readouts, including the cytokines IFNγ, IL5 and IL13 and transcription-factor responses, depended on macrophage state and carrier conditions. This makes the producing cell and its surroundings part of the local-response explanation.

The carrier-protein boundary is important. The maximum tested vitamin D-binding protein concentration was below the usual blood concentration cited in the study. The result cannot therefore be described as proof that macrophages overcome all binding constraints in ordinary serum. The laboratory state labels also do not divide every macrophage in living tissues into two permanent, uniform classes.

This study and Kongsbak’s work came from a connected Copenhagen research programme, with distinct experiments. That is not independent-laboratory replication, and a shared programme does not establish that the same donors were reused. Neither study measured each tissue’s contribution to whole-body hormone flux. Together they show that cellular state and local availability are material variables, while leaving the precise balance of routes in an intact person unresolved. The wider tissue comparison is introduced in Tissue-Specific Vitamin D Metabolism.

A defined T-cell circuit links metabolism with a response programme

Chauss and colleagues, published online in 2021 and in the 2022 issue, investigated activated human T cells, including a CD46-associated activation context. CD46 is a cell-surface protein linked with complement signalling. Perturbations supported roles for CYP27B1 and VDR in the specified response programme. A functional contrast concerned IL6 signalling: blocking its receptor reduced IL10 output and STAT3 phosphorylation, an activation-related protein change, without the same reduction in total STAT3 induction. This distinguishes an experimentally tested signalling step from simple co-expression and links the pathway with a measured cytokine response.

That is more specific than saying vitamin D simply boosts or suppresses immunity. A response can change direction or timing within a particular activation programme, while other cells and other outputs behave differently. IL10 production is not, by itself, proof that the cells became a generic regulatory T-cell population or that an inflammatory illness resolved.

The cell-intrinsic pathway does not establish that every active-hormone molecule remained inside its producing cell. Autocrine or neighbouring-cell contributions are not excluded by the population measurements. Disease-associated observations in the paper do not supply a randomized treatment test. The useful contribution here is the link between a specified metabolic/receptor circuit and selected cellular responses, without converting that mechanism into clinical recovery or an exhaustive list of regulated genes.

Finding active hormone outside the kidney

Meyer and colleagues in 2024 used targeted chemical imaging and confirmatory mass spectrometry in a renal-enhancer pseudo-null mouse model: regulatory DNA had been altered to strongly suppress kidney Cyp27b1 expression. Normal and global Cyp27b1-null comparators helped interpret the source question. The experiments supported calcitriol detection outside the kidney, particularly in the spleen. Selected splenic gene responses also changed: Il4 increased and Tnfa decreased, while several other tested cytokines did not clearly change. This adds organ-scale location and response evidence to the cell-culture findings.

The imaging groups were small, with three biological samples, and spatial resolution and tissue processing limit cellular attribution. A measured signal in a splenic region does not identify every producing cell or prove that the detected hormone never moved from another compartment. The dietary and genetic conditions also differed from ordinary human physiology. Animals receiving a diet without added vitamin D were not shown to be serum-deficient at the examined time.

The study therefore supports a nonrenal product and selected response under those conditions, rather than a measured rate of hormone export to blood. It does not establish a uniform cytokine response or general immune benefit. The unchanged readouts are part of the result: detecting active hormone in a tissue does not mean every proposed downstream gene responds together.

A maintained blood level can hide altered physiology

Lee and colleagues in 2025 examined Cyp27b1 deletion using Six2 and Pax8 targeting systems. Circulating calcitriol remained within the normal-comparator range in both. Six2 findings were relatively mild; the more affected Pax8 model had higher parathyroid hormone and lower bone mineral density, with lower calcium in males. A maintained blood active-hormone result therefore did not establish that the physiological system was otherwise normal.

Remaining renal activity, increased nonrenal production and reduced breakdown are possible contributions, but their fluxes and hormone half-life were not separately measured. Low gene RNA also does not prove complete absence of protein activity. Pax8 targeting additionally affects thyroid and parathyroid tissues, which matters when interpreting an endocrine endpoint. These restrictions prevent treating the result as proof that all circulating hormone came from nonrenal tissue or that kidneys are unnecessary.

This qualitative interpretation uses the complete reported main findings and limitations; it does not reconstruct numerical graph values. Lee’s work and the preceding imaging study belong to a connected research programme, with different experiments. Together they provide a useful cross-check on an overly simple blood-to-tissue inference, while leaving the quantitative balance of sources and removal unresolved.

Metabolite profiles and compensation need separate measurements

Meyer and colleagues in 2019 studied regulation of Cyp24a1 using altered regulatory DNA in mice. The contribution used here is the tabulated metabolic comparison: changes in precursor and breakdown-product profiles could coexist with preserved selected circulating calcitriol and mineral measurements. This is evidence that disruption of one part of metabolism need not produce the same change in every blood endpoint.

That comparison helps frame the activation and clearance studies without assigning an unmeasured local set point. A circulating balance may reflect responses elsewhere in the system, and an unchanged concentration does not identify which compensatory route mattered. The result does not supply a tissue-specific clearance rate, hormone half-life or direct measurement of intracellular exposure.

The appraisal here is restricted to the inspected metabolic tables. It does not claim a new visual assessment of the paper’s enhancer tracks or derive precise tissue contrasts from unseen graphs. Some comparisons in the publication reuse earlier mutant data; those panels do not become extra independent studies. This work is related to the Meyer/Lee programme and provides a bounded metabolic-profile qualification, rather than independent replication of every later organ-specific result. The broader regulatory context is developed in Why CYP27B1 and CYP24A1 Behave Differently Across Tissues.

Does intestinal breakdown regulate local responses?

Fuchs and colleagues, published online in 2024 and in the 2025 issue, compared deletion of Cyp24a1 in different mouse compartments. Renal deletion increased circulating active vitamin D and produced mild hypercalcaemia on the standard-calcium diet. Intestinal deletion increased the local targets Trpv6 and S100g without a corresponding rise in circulating vitamin D metabolites. These genes relate to calcium transport, but their RNA is not itself a measurement of absorption. The comparison challenges the assumption that every local metabolic effect must appear as a similar blood change.

The renal deletion was developmental, whereas the intestinal intervention was induced in adults. The intestinal study included a 12-week follow-up to about 24 weeks of age and tested standard 0.8% or high 2% calcium diets. These are experimental dietary conditions, not human intake recommendations. Mineral, endocrine and urinary observations supported the local-versus-systemic interpretation; calcium absorption was inferred rather than measured directly as a flux.

The distinction matters for physiological language. An increase in an intestinal transport-gene message is evidence of a local transcriptional response. It does not automatically quantify calcium movement through the intestine or identify the exact local calcitriol concentration responsible. The study supplies a strong organ-perturbation comparison, but its local target-gene finding needs to be read alongside the contrary experiment below.

The conflicting intestinal result remains unresolved

Fleet and colleagues in 2025 compared adult whole-body Cyp24a1 deletion with a separate intestine-specific deletion model. Whole-body deletion increased circulating precursor and active hormone. The intestinal comparison found no statistically significant change in circulating vitamin D metabolites or the selected duodenal targets Trpv6 and S100g. Thus the two papers agree on the lack of a clear intestinal-deletion blood-metabolite rise but differ on local target-gene responses.

Fleet used constitutive intestinal deletion and assessment at about 12 weeks of age, with a final seven-day controlled diet containing 0.5% calcium. Fuchs used adult induction, a 12-week follow-up to about 24 weeks, and the higher-calcium diet settings described above. These documented differences offer explanations to investigate, but do not establish which caused the discrepancy. In particular, a proposed effect of the induction treatment was not isolated in a matched experiment and is not an established resolution.

Fleet did not report the full mineral/endocrine panel measured in Fuchs, direct intestinal calcitriol or absorption flux. A nonsignificant result without an equivalence margin does not prove that the local effect is zero under every condition. Detection of mutant enzyme RNA does not establish that functional enzyme is present, and a reported trend in renal expression does not confirm compensation. The comparison here remains qualitative because graph-level numerical precision was not verified.

The unresolved disagreement is scientifically useful. It limits a universal prediction that removing intestinal CYP24A1 always changes the same local genes. It also prevents treating blood-metabolite agreement as agreement about every tissue response. A defensible synthesis retains both findings and their design differences, rather than selecting the result that makes the mechanism look simplest.

Protein processing and related enzymes add another layer

Uga and colleagues in 2024 combined cellular reporter experiments, protein-processing measurements and intestinal Vdr perturbation in mice. In the cell experiments, CYP24A1 and related CYP3A enzymes reduced ligand-dependent reporter responses under the tested expression conditions. Altering a mitochondrial targeting region did not reproduce the intact enzyme’s effect. This illustrates why an enzyme transcript or partial protein is not interchangeable with a correctly processed and located enzyme.

In the mouse work, intestinal receptor deletion altered local protein and metabolite responses while renal CYP24A1 responses remained. However, deleting Vdr changes a regulatory receptor, not only the breakdown enzyme. The resulting plasma-metabolite difference cannot be assigned exclusively to intestinal CYP24A1 flux. The acute mouse experiment also did not show corresponding induction of the tested Cyp3a11/13 genes.

Overexpression, cancer-derived cell models, low baseline expression and an acute animal exposure limit physiological generalisation. The study supports roles for processing, targeting and alternative metabolic pathways within its systems. It does not quantify each enzyme’s normal contribution in human intestine. This qualifies a one-enzyme explanation of local exposure without replacing it with another universal formula. The sequence from conversion to removal is connected in From Vitamin D Activation to Clearance: The CYP27B1: CYP24A1 Balance.

Metabolic exposure is only part of tissue-specific gene regulation

The metabolic studies establish several reasons why local exposure can differ: precursor access, activation time, the producing cell’s state, enzyme processing and removal. That is a bounded synthesis across experiments, not a direct measurement of one complete pathway in every tissue. It does not show that metabolism explains all differences between cell types, or that all the studies supplied identical serum or intracellular exposure.

The broader comparison in Vitamin D-Responsive Gene Expression Across Cells and Tissues: Full Evidence Review supplies another part of the question. Human intestinal cultures differed by gut segment and differentiation state. RNA and protein could also change on different time courses. These findings mean that a tissue-specific account must consider the responding cells and the measurement time, rather than assigning every different gene response to a different amount of locally made hormone.

That review also contrasts short, uncontrolled blood-cell observations after vitamin D3 with a longer randomized whole-blood trial that found no clear gene-expression response under its analysis. Population, exposure, timing, sample composition and comparator differed. A late blood null does not exclude every earlier or rare-cell response, while an uncontrolled short response does not establish treatment benefit. Neither comparison isolates metabolism as the cause of the difference.

Vitamin D, Chromatin Accessibility and Epigenetic Marks: Full Evidence Review addresses the regulatory environment. DNA accessibility, protein occupancy and chemical marks are distinct measurements. Some expression responses occurred at regions already accessible, and some accessibility changes were transient. Limited biological replication and nominal or null human findings constrain stronger claims. These observations prevent assuming that active hormone must open new DNA regions, create lasting epigenetic memory or produce a beneficial programme in every tissue.

The combined account therefore retains both metabolic and regulatory context. Local ligand availability helps define what a cell can encounter; receptor/co-regulator function and chromatin help shape how it responds. RNA production, protein abundance and physiological performance remain further measurements. The selected experiments do not establish one of these layers as the dominant explanation in every tissue, and the shared response/chromatin studies are not additional independent replications of the ten metabolic studies. The receptor’s role is introduced in Vitamin D Receptors.

Following the evidence from molecules to physiology

The strongest interpretation depends on the endpoint. The skin study connects perturbations with selected recognition and antimicrobial gene responses, but not clinical healing. The defined T-cell circuit connects metabolism and receptor signalling with cytokine output, but not recovery from illness. The splenic imaging study adds a spatial chemical measurement and selected gene changes, while leaving cell-level origin and tissue-to-blood flux unresolved.

The mouse clearance studies test organ-level perturbations, yet their local target-gene discrepancy remains open. Transport-gene RNA is not a direct calcium-absorption measurement. Likewise, the renal-activation follow-up demonstrates that an apparently maintained blood hormone level can coexist with altered bone and endocrine findings. A biomarker can therefore be informative without standing in for the whole physiological system.

No single study completes every step from precursor entry to improved tissue function. The synthesis is stronger when it identifies where conversion, product, gene expression or physiology was actually measured and where the next step remains an inference. It becomes weaker if an observed change is described with a broader functional label, such as healing, protection or resilience, that the experiment did not test.

What the evidence supports and leaves open

The ten studies are materially different experiments, but they are not ten independent laboratories confirming one benefit. Several Meyer/Lee papers share a research programme, some earlier comparison data are reused, and the T-cell/macrophage studies have programme connections. Several experimental arms within a publication remain one study. The shared gene-response and chromatin reviews answer additional questions without multiplying the underlying metabolic experiments.

Together the evidence supports tissue-dependent vitamin D metabolism and conditional downstream responses. It also shows why a blood concentration cannot, by itself, specify every local rate or effect. The unresolved intestinal disagreement, species-specific responses, unchanged genes and maintained blood hormone despite altered physiology all limit a simple universal model.

The remaining questions concern quantities and causal connections: how much active hormone is made or removed in a particular intact tissue, which cells use it, what regulatory state they occupy, and whether the measured molecular response changes a physiological outcome. These studies help define those questions. They do not establish a universal local target concentration, a personal supplement regimen or a general clinical benefit from increasing vitamin D exposure.

Sources

Related reading

Original sources

Source

Vitamin D-binding protein controls T cell responses to vitamin D

In vitro studies have shown that the active form of vitamin D3, 1α,25-dihydroxyvitamin D3 (1,25(OH)2D3), can regulate differentiation of CD4+ T cells by inhibiting Th1 and Th17 cell differentiation and promoting Th2 and Treg cell differentiation.

Publication details

Vitamin D-binding protein controls T cell responses to vitamin D. Kongsbak M, von Essen MR, Levring TB, et al. BMC immunology. 2014;15:35. DOI: 10.1186/s12865-014-0035-2.

Read more →
Source

Spatial detection and consequences of nonrenal calcitriol production as assessed by targeted mass spectrometry imaging

Here, utilizing on-tissue chemical derivatization and matrix assisted laser desorption ionization-mass spectrometry imaging (MALDI-MSI), we investigated the distribution of 1,25(OH)2D3 and 25(OH)D3 in the kidney, liver, spleen, and thymus.

Publication details

Spatial detection and consequences of nonrenal calcitriol production as assessed by targeted mass spectrometry imaging. Meyer MB, Lee SM, Cichanski SR, et al. JCI insight. 2024;9(15):e181763. DOI: 10.1172/jci.insight.181763.

Read more →
Source

Kidney deletions of Cyp27b1 fail to reduce serum 1,25(OH)2D3

Published in Lee SM, Cichanski SR, Pintozzi NG, et al. The Journal of steroid biochemistry and molecular biology (2025).

Publication details

Kidney deletions of Cyp27b1 fail to reduce serum 1,25(OH)2D3. Lee SM, Cichanski SR, Pintozzi NG, et al. The Journal of steroid biochemistry and molecular biology. 2025;250:106734. DOI: 10.1016/j.jsbmb.2025.106734.

Read more →
Source

A chromatin-based mechanism controls differential regulation of the cytochrome P450 gene Cyp24a1 in renal and non-renal tissues

Published in Meyer MB, Lee SM, Carlson AH, et al. The Journal of biological chemistry (2019).

Publication details

A chromatin-based mechanism controls differential regulation of the cytochrome P450 gene Cyp24a1 in renal and non-renal tissues. Meyer MB, Lee SM, Carlson AH, et al. The Journal of biological chemistry. 2019;294(39):14467 to 14481. DOI: 10.1074/jbc.RA119.010173.

Read more →
Source

The impact of inducible-whole body or intestine-specific Cyp24a1 gene knockout on vitamin D metabolism in mice

Published in Fleet JC, Watkins NM, Anderson PH, et al. The Journal of steroid biochemistry and molecular biology (2025).

Publication details

The impact of inducible-whole body or intestine-specific Cyp24a1 gene knockout on vitamin D metabolism in mice. Fleet JC, Watkins NM, Anderson PH, et al. The Journal of steroid biochemistry and molecular biology. 2025;250:106735. DOI: 10.1016/j.jsbmb.2025.106735.

Read more →